178 related articles for article (PubMed ID: 7901016)
1. Epstein-Barr virus infection in HIV-positive patients.
Telenti A; Uehlinger DE; Marchesi F; Germann D; Malinverni R; Matter L
Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):601-9. PubMed ID: 7901016
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV.
Brousset P; Drouet E; Schlaifer D; Icart J; Payen C; Meggetto F; Marchou B; Massip P; Delsol G
AIDS; 1994 May; 8(5):583-90. PubMed ID: 7914731
[TBL] [Abstract][Full Text] [Related]
3. Tumor specific Epstein-Barr virus infection is not associated with leiomyosarcoma in human immunodeficiency virus negative individuals.
Hill MA; Araya JC; Eckert MW; Gillespie AT; Hunt JD; Levine EA
Cancer; 1997 Jul; 80(2):204-10. PubMed ID: 9217031
[TBL] [Abstract][Full Text] [Related]
4. Antibody responses to two Epstein-Barr virus (EBV) nuclear antigens (EBNA-1 and EBNA-2) during EBV primary infection in children born to mothers infected with human immunodeficiency virus.
Pedneault L; Lapointe N; Alfieri C; Ghadirian P; Carpentier L; Samson J; Joncas J
Clin Infect Dis; 1996 Oct; 23(4):806-8. PubMed ID: 8909848
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus DNA in the blood of infants, young children, and adults by age and HIV status.
Brandt CD; Sison AV; Rakusan TA; Saxena ES; Kaufman TE; O'Donnell RM; Sever JL
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jan; 17(1):69-72. PubMed ID: 9436761
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Epstein-Barr virus-infected cells in benign lymphadenopathy of patients seropositive for human immunodeficiency virus.
Brousset P; Schlaifer D; Roda D; Massip P; Marchou B; Delsol G
Hum Pathol; 1996 Mar; 27(3):263-8. PubMed ID: 8600041
[TBL] [Abstract][Full Text] [Related]
8. Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection.
Legoff J; Amiel C; Calisonni O; Fromentin D; Rajoely B; Abuaf N; Tartour E; Rozenbaum W; Bélec L; Nicolas JC
J Clin Immunol; 2004 Mar; 24(2):125-34. PubMed ID: 15024179
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.
Santos L; Azevedo K; Silva L; Oliveira L
Rev Assoc Med Bras (1992); 2014; 60(3):262-9. PubMed ID: 25004273
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
[TBL] [Abstract][Full Text] [Related]
11. Development of EBV-positive T-cell lymphoma following infection of peripheral blood T cells with EBV.
Kanegane H; Miyawaki T; Yachie A; Oh-Ishi T; Bhatia K; Tosato G
Leuk Lymphoma; 1999 Aug; 34(5-6):603-7. PubMed ID: 10492086
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.
Kahn JA; Rudy BJ; Xu J; Kapogiannis B; Secord E; Gillison M
J Med Virol; 2016 Nov; 88(11):1944-52. PubMed ID: 27096166
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study.
Basso M; Andreis S; Scaggiante R; Franchin E; Zago D; Biasolo MA; Del Vecchio C; Mengoli C; Sarmati L; Andreoni M; Palù G; Parisi SG
BMC Infect Dis; 2018 Dec; 18(1):683. PubMed ID: 30567494
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
15. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals.
Yao QY; Tierney RJ; Croom-Carter D; Dukers D; Cooper GM; Ellis CJ; Rowe M; Rickinson AB
J Virol; 1996 Aug; 70(8):4884-94. PubMed ID: 8763991
[TBL] [Abstract][Full Text] [Related]
16. Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients.
Martinez OM; Villanueva JC; Lawrence-Miyasaki L; Quinn MB; Cox K; Krams SM
Transplantation; 1995 Feb; 59(4):519-24. PubMed ID: 7878757
[TBL] [Abstract][Full Text] [Related]
17. Significance of Epstein-Barr virus (HHV-4) and CMV (HHV-5) infection among subtype-C human immunodeficiency virus-infected individuals.
Sachithanandham J; Kannangai R; Pulimood SA; Desai A; Abraham AM; Abraham OC; Ravi V; Samuel P; Sridharan G
Indian J Med Microbiol; 2014; 32(3):261-9. PubMed ID: 25008818
[TBL] [Abstract][Full Text] [Related]
18. Malignant lymphoma of the urethra: report of a case with detection of Epstein-Barr virus genome in the tumour cells.
Ohsawa M; Mishima K; Suzuki A; Hagino K; Doi J; Aozasa K
Histopathology; 1994 Jun; 24(6):525-9. PubMed ID: 8063280
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus infection in nasopharyngeal carcinoma.
Raab-Traub N
Infect Agents Dis; 1992 Aug; 1(4):173-84. PubMed ID: 1365543
[TBL] [Abstract][Full Text] [Related]
20. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology.
Stevens SJ; Blank BS; Smits PH; Meenhorst PL; Middeldorp JM
AIDS; 2002 May; 16(7):993-1001. PubMed ID: 11953465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
